These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22151800)

  • 1. Digitate hyperkeratosis.
    Gulia A; Di Cesare A; Peris K
    J Dtsch Dermatol Ges; 2012 Feb; 10(2):136-7. PubMed ID: 22151800
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
    Sarnoff DS; Saini R
    J Drugs Dermatol; 2008 May; 7(5):475-8. PubMed ID: 18505142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermolytic hyperkeratosis: a follow-up of 23 years of use of systemic retinoids.
    Nassif PW; Nakandakari S; Fogagnolo L; Contin LA; Alves CJ
    An Bras Dermatol; 2011; 86(4 Suppl 1):S72-5. PubMed ID: 22068776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidcermolytic hyperkeratosis: a case report.
    Achar A; Naskar B; Laha R; Ray S
    J Indian Med Assoc; 2009 Mar; 107(3):171-2. PubMed ID: 19810387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperkeratosis lenticularis perstans (Flegel's disease) - a complex disorder of epidermal differentiation with good response to a synthetic vitamin D3 derivate].
    Metze D; Lübke D; Luger T
    Hautarzt; 2000 Jan; 51(1):31-5. PubMed ID: 10663037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child.
    Bogenrieder T; Landthaler M; Stolz W
    Acta Derm Venereol; 2003; 83(1):52-4. PubMed ID: 12636025
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of tazarotene on ichthyosiform erythroderma of Tay's syndrome.
    Varghese VS; Rai R; Sundaram SV; Prabhu KS; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2007; 73(2):126-7. PubMed ID: 17456926
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrokeratoderma variabilis successfully treated with topical tazarotene.
    Yoo S; Simzar S; Han K; Takahashi S; Cotliar R
    Pediatr Dermatol; 2006; 23(4):382-5. PubMed ID: 16918639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful topical adapalene treatment for the facial lesions of an adolescent case of epidermolytic ichthyosis.
    Ogawa M; Akiyama M
    J Am Acad Dermatol; 2014 Sep; 71(3):e103-5. PubMed ID: 25128122
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of mosaic-type bullous congenital ichthyosiform erythroderma successfully treated with topical maxacalcitol, a vitamin D3 analogue.
    Umekoji A; Fukai K; Ishii M
    Clin Exp Dermatol; 2008 Jul; 33(4):501-2. PubMed ID: 18498407
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermolytic hyperkeratosis (bullous ichthyosis).
    Khatri ML; Shafi M; Ben-Ghazeil M
    J Eur Acad Dermatol Venereol; 2000 Jul; 14(4):324-5. PubMed ID: 11204534
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythrokeratodermia variabilis with adult onset: report of a sporadic case unresponsive to systemic retinoids.
    Erbagci Z; Tuncel AA; Deniz H
    J Dermatolog Treat; 2006; 17(3):187-9. PubMed ID: 16854764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolytic hyperkeratosis with ichthyosis hystrix.
    Baleviciené G; Schwartz RA
    Cutis; 2000 Nov; 66(5):319-22. PubMed ID: 11107513
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinoid therapy for psoriasis.
    Yamauchi PS; Rizk D; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial epidermolytic ichthyosis.
    Das A; Das A; Bhattacharya S; Ghosh A; Shome K
    Indian J Dermatol Venereol Leprol; 2015; 81(6):656. PubMed ID: 26515868
    [No Abstract]   [Full Text] [Related]  

  • 16. Meeting a rare disease: bullous ichthyosiform erythroderma.
    Tonini G; Trovato E; Pellegrino M; Fimiani M
    G Ital Dermatol Venereol; 2020 Dec; 155(6):783-784. PubMed ID: 29998711
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical treatment of infections, tumors and hyperkeratotic disorders].
    Messerschmidt A; Schultheis K; Ochsendorf F
    Hautarzt; 2014 Mar; 65(3):207-17. PubMed ID: 24500043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders.
    Verfaille CJ; Borgers M; van Steensel MA
    J Dtsch Dermatol Ges; 2008 May; 6(5):355-64. PubMed ID: 17941881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital unilateral reticulate keratotic papules on the lower extremity.
    Bains A; Singh S
    Int J Dermatol; 2018 Apr; 57(4):399-400. PubMed ID: 29165799
    [No Abstract]   [Full Text] [Related]  

  • 20. Unilateral nevoid hyperkeratosis of the nipple: a report of two cases.
    Shastry V; Betkerur J; Kushalappa PA
    Indian J Dermatol Venereol Leprol; 2006; 72(4):303-5. PubMed ID: 16880580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.